Blood Replacement
9 Blood Replacement Kenneth B. Hymes The transfusion of blood products in the perioperative setting is often necessary to provide adequate tissue oxygenation and to maintain hemostasis.1–3 The benefits of…
Preoperative Non-Hematologic Adjuvant Methods for Preventing Blood Loss
16 Preoperative Non-Hematologic Adjuvant Methods for Preventing Blood Loss Alejandro Santillan, Walter Zink, Lewis Leng, Shaun David Rodgers, and Howard A. Riina During the initial evaluation of a cranial or…
Hematologic Adjuvant Treatment for Preventing and Treating Blood Loss in Pediatric Neurosurgery
28 Hematologic Adjuvant Treatment for Preventing and Treating Blood Loss in Pediatric Neurosurgery Julia Sharma, John R.W. Kestle, and Ash Singhal Pediatric blood loss can be a major concern during…
Risk of Anticoagulants and Antiplatelet Agents in Spine Surgery Patients
25 Risk of Anticoagulants and Antiplatelet Agents in Spine Surgery Patients Aaron Hockley, Perry Dhaliwal, and W. Bradley Jacobs Several unique aspects of spinal surgery require surgeons to have a…
Neuroendovascular Issues
21 Neuroendovascular Issues Alim P. Mitha, Michael K. Tso, Felipe C. Albuquerque, Cameron G. McDougall, and John H. Wong Manipulation of catheters, coils, balloons, and stents within the blood vessels…
Principles of Blood and Volume Replacement
8 Principles of Blood and Volume Replacement Rami O. Almefty, Tsinsue Chen, and Peter Nakaji A thorough understanding of indications for blood replacement is essential for all neurosurgeons. The breadth…
Venous Thromboembolism (DVT and PE): Prophylaxis
11 Venous Thromboembolism (DVT and PE): Prophylaxis Ryan Morton and Samuel R. Browd An Introduction to the Rationale for Mechanical and Chemical Deep Venous Thrombosis Prophylaxis in Neurosurgery Patients Venous…
Risk of Anticoagulants and Antiplatelet Agents in Brain Tumor Patients
18 Risk of Anticoagulants and Antiplatelet Agents in Brain Tumor Patients David J. Daniels and Ian F. Parney Patients with primary or metastatic brain tumors are predisposed to venous thromboembolism…
Risk of Anticoagulants and Antiplatelet Agents in Patients with Brain and Spinal Catheters
27 Risk of Anticoagulants and Antiplatelet Agents in Patients with Brain and Spinal Catheters Benjamin A. Rubin and Jeffrey H. Wisoff The balance between prevention of thrombotic phenomena and hemorrhagic…
